Screener
ImmunityBio, Inc. IBRX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Common Stock, $0.0001 par value; 1,650,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 1,047,341,146 and 1,011,800,008 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively; excluding treasury stock, 163,800 shares outstanding as of March 31, 2026 and December 31, 2025 | $104 | $101 |
| Additional paid-in capital | 3,461,865 | 3,197,120 |
| Accumulated deficit | (4,359,428) | (3,726,646) |
| Accumulated other comprehensive income | 27,453 | 28,956 |
| Total ImmunityBio stockholders’ deficit | (870,006) | (500,469) |
| Noncontrolling interests | 880 | 895 |
| Total stockholders’ deficit | (869,126) | (499,574) |
| Total liabilities and stockholders’ deficit | $646,637 | $501,898 |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is ImmunityBio, Inc.'s total equity?
- ImmunityBio, Inc. (IBRX) reported total equity of -$870.01M in Q1 2026.
- How has ImmunityBio, Inc.'s total equity changed year-over-year?
- ImmunityBio, Inc.'s total equity decreased by 47.1% year-over-year, from -$591.43M to -$870.01M.
- What is the long-term trend for ImmunityBio, Inc.'s total equity?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s total equity has grown at a 33.1% compound annual growth rate (CAGR), from -$119.81M to -$500.47M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about ImmunityBio, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude